预约演示
Aveanna Healthcare Holdings Announces Agreement to Extend its $175 Million Securitization Facility
Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH), a leading provider of care in the home to pediatric, adults, and geriatric patients, announced that it has amended its securitization facility to extend its maturity to July 31, 2026. The amended agreement continues to provide for total availability of $175 million.
Matt Buckhalter, Interim CFO of Aveanna, stated, “We are pleased to extend this credit facility with our banking partners. We believe that this facility provides ample liquidity for our business to invest in growth while focusing on our strategies of value-based care in the home. We remain confident in our balance sheet, and we thank our credit partners for their trust in us.”
Additional information may be found in the Company’s Current Report on Form 8-K filed today with the Securities and Exchange Commission. The company is scheduled to report its second quarter earnings on Thursday, August 10, 2023.
About Aveanna Healthcare
Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 33 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization.
The content above comes from the network. if any infringement, please contact us to modify.
适应症
-靶点
-药物
-Eureka LS:
全新生物医药AI Agent 覆盖科研全链路，让突破性发现快人一步
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。